If you or a loved one has taken Reglan to treat short-term heartburn or gastrointestinal issues associated with diabetes, be aware that as early as February of 1996, the FDA warned that Reglan causes an increased risk of Parkinsonism. Moreover, recently published analyses suggest that Reglan is the most common cause of two severe drug-induced movement disorders such as tardive dyskinesia and neuroleptic malignant syndrome. On February 26, 2009, the FDA announced that manufacturers of Reglan must add a Black Box Warning to all information regarding Reglan, stating that long-term or high-dose use of this drug has been linked to tardive dyskinesia.¬† Specifically, all patients who take Reglan, and doctors who prescribe of Reglan, must be warned that it ‚Äúhas been shown to cause spasms and tics when used for long periods of time or at high doses. The problems include uncontrollable movement of the limbs, face and tongue, and are usually irreversible, even after patients stop taking the drug.‚ÄĚ Although the prevalence of neurological impairment appears to be highest among the elderly, especially elderly women, it is impossible to predict which patients are likely to develop side effects, making Reglan a very dangerous medication.
‚ÄúThe chronic use of Metoclopramide (Reglan) therapy should be avoided in all but rare cases where the benefit is believed to outweigh the risk,‚ÄĚ stated Janet Woodcock, director of the FDA‚Äôs Center for Drug Evaluation and Research, in a statement issued recently.
Drug: Reglan (Metoclopramide)
Condition: for the treatment of heartburn and/or digestive issues associated with diabetes and other conditions
Complications: tardive dyskinesia, neuroleptic malignant syndrome
If you or a loved one took Reglan and have experienced any of these symptoms or side effects, Click HERE for a free evaluation of your case by the Law Offices of Brian D. Witzer.